Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Huge step forward for the CBD industry as this trial proved no liver toxicity in the 839 participants
HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety
https://www.businesswire.com/news/home/20210323005376/en/HempFusion-Wellness-Announces-Toxicology-Results-from-Validcare’s-Clinical-Study-on-CBD-Liver-Safety
Branded Legacy, Inc. Acquires Versatile Industries, LLC
https://finance.yahoo.com/amphtml/news/branded-legacy-inc-acquires-versatile-125000200.html
Branded Legacy, Inc. Acquires Versatile Industries, LLC
https://finance.yahoo.com/amphtml/news/branded-legacy-inc-acquires-versatile-125000200.html
Very nice day for CANB
TLRY Float was approx. 8.8M when it went from $20 to $300. Just need the market and more importantly the cannabis sector to turn around. Shareholders were notified 9 months ago about the RS to prepare for Nasdaq listing. Nothing new here.
CANB Market Cap ~$5.5M
Market Cap approx. 5.5M :)
Thank you
Anyone have the official OS and float(unrestricted)?
“With the exception of hemp or cannabidiol (CBD), McConnell has no intention of reforming the marijuana industry.”
CBD is in, THC is out
https://www.fool.com/amp/investing/2020/02/22/bank-on-it-the-safe-banking-act-wont-pass-in-2020.aspx
“With the exception of hemp or cannabidiol (CBD), McConnell has no intention of reforming the marijuana industry.”
CBD is in, THC is out
https://www.fool.com/amp/investing/2020/02/22/bank-on-it-the-safe-banking-act-wont-pass-in-2020.aspx
Good morning everybody
All the other cannabinoids are NEW ingredients, hence —
“If the dietary supplement contains a NEW ingredient, manufacturers must notify FDA about that ingredient prior to marketing. However, the notification will only be reviewed by FDA (not approved) and only for safety, not effectiveness.”
https://www.fda.gov/food/buy-store-serve-safe-food/what-you-need-know-about-dietary-supplements
Let’s KISS - Keep It Simple Stupid
Why did the largest cannabis producer, Canopy Growth, decide to go with Pure CBD for their two CBD lines (First & Free, Biosteel)?
My answer — Canopy/Constellation knows that the first formulation to be allowed to sell nationally will be Pure CBD.
Canbiola is the only Pure Play CBD-Isolate Oil stock.
CBN, CBG, CBC, and all the other 100+ cannabinoids will not meet all the FD&C Safety requirements — the vast number of cannabinoids have not been studied at all, thus safety cannot be assured.
SUBCHAPTER IV—FOOD
f) Dietary supplement or ingredient: safety
(1) If it is a dietary supplement or contains a dietary ingredient that—
(A) presents a significant or unreasonable risk of illness or injury under—
(i) conditions of use recommended or suggested in labeling, or
(ii) if no conditions of use are suggested or recommended in the labeling, under ordinary conditions of use;
(B) is a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury;
(C) the Secretary declares to pose an imminent hazard to public health or safety, except that the authority to make such declaration shall not be delegated and the Secretary shall promptly after such a declaration initiate a proceeding in accordance with sections 554 and 556 of title 5 to affirm or withdraw the declaration; or
(D) is or contains a dietary ingredient that renders it adulterated under paragraph (a)(1) under the conditions of use recommended or suggested in the labeling of such dietary supplement.
In any proceeding under this subparagraph, the United States shall bear the burden of proof on each element to show that a dietary supplement is adulterated. The court shall decide any issue under this paragraph on a de novo basis.
(2) Before the Secretary may report to a United States attorney a violation of paragraph 2 (1)(A) for a civil proceeding, the person against whom such proceeding would be initiated shall be given appropriate notice and the opportunity to present views, orally and in writing, at least 10 days before such notice, with regard to such proceeding.
https://uscode.house.gov/view.xhtml?path=/prelim@title21/chapter9/subchapter4&edition=prelim
As always, thank you.
I disagree with you. Now is the time to be adding as much as you can in my opinion.
Pure CBD (CBD ISOLATE) will be the formulation allowed in supplements and food/beverage to be sold nationally. H.R.5587 legislation which was recently introduced will allow the national sale of Pure CBD.
https://www.jdsupra.com/legalnews/bipartisan-bill-for-federal-regulation-15308/
Also, the largest cannabis company — Canopy Growth — chose Pure CBD for their two CBD brands (First & Free, Biosteel). So, CANB is the only Pure Play CBD Isolate publicly traded company that I’m aware of at this time.
https://www.directcbdonline.com/brand/first-and-free/
https://www.directcbdonline.com/?s=biosteel+&product_cat=0&post_type=product
Moreover, recent decline in share price is not CANB specific — it’s sector specific. Anyone who’s been investing/trading cannabis stocks from 2013 realizes that the sector rises and drops together. I’m expecting a turnaround for the sector next week in anticipation for industry earnings and an update from congress on CBD legislation.
https://marijuanaindex.com
I will be buying CANB until the beast is released
Best of luck to you
Now is the to time add/buy!
Today & Tomorrow! Come visit the Canbiola booth at EVOLVE Conference — Salt Lake City, UTAH — Feb 8 & 9, 2020
Today & Tomorrow! Come visit the Canbiola booth at EVOLVE Conference — Salt Lake City, UTAH — Feb 8 & 9, 2020
— Can B Corp. (@CanBCorp) February 8, 2020
#evolve2020 #cbd #doctor #md #medical #expo #evolve2020 pic.twitter.com/9W3BBPxvaD
Read sleekscape’s post on the Nasdaq uplisting and RS — it’s a sticky post. It’s an excellent read.
From the post:
Future Dilution due to Convertible Debt — Does not apply, CANB has zero convertible debt
Convertible debt needs to be discharged by issuing shares and the number of shares outstanding is bumping up along the number of shares authorized, so the company has no choice but to either increase the number of shares outstanding or perform a reverse split in order to accommodate these additional shares — CANB has zero convertible debt, so this situation doesn’t apply here
Management owns preferred shares and wants to reclaim majority ownership in the company — also doesn’t apply here
This situation occurs when management sets the terms of the reverse split to apply differently to their preferred shares vs common shares — the common shares are subject to the reverse split and the preferred shares are protected from the reverse split — there is no language in CANB’s filing that protects the preferred shares, but I contacted the company just to confirm: “Everybody is in the same boat, if we do go ahead and perform the reverse, all shares will be included.”
A reverse stock split does not affect the company's value. Also, the total value of the stock held by an investor will not change after a reverse stock split.
CANB is in a very unique position to be the first CBD Oil stock to trade on the Nasdaq as they’re the only Pure CBD (CBD Isolate) Oil stock, but the only way for CANB to accomplish this is with an RS to meet the minimum share price requirement.
With Banking and CBD Legalization passing, Nasdaq will accept CBD stocks that make products without THC.
Regardless, of RS or not, CANB will be a top % gainer when the CBD sector turns around. I continue to buy all dips and hold my shares tight. All evidence points to Pure CBD being the first formulation to be allowed to sell nationally.
Good morning everybody!
I like it more than you
CANBeast!
Excellent support. No RS and approx. 1.2B shares returned to treasury. Low Float.
“The company currently has manufacturing capacity of up to $40 million at wholesale in our Lacey, Washington R&D lab and production facility and through its targeted sales efforts the company looks to capitalize on this available capacity. Parties interested in a high volume, lower cost, high quality private label production should contact the company directly.“
“the year’s first significant white label contract for CBD products for a multi-unit operator in the Eastern United States. The company has signed to provide private label products to the Canbiola custom specifications in our premium label series.”
Excellent News today!
Sugarmade has been presented with numerous other business combination opportunities that its board of directors now believes are superior and are under consideration.
The Company’s board of directors believes entry into the regulated portion of the cannabis business sector, which includes hemp and legal THC cannabis cultivation, processing and marketing, is particularly appealing due to the large number of assets within that sub-sector that are currently available for purchase or acquisition. Sugarmade has entered into discussion with several such companies relative to a strategic business combination.
“...the Company has placed a hold on plans to complete a reverse split of its common shares. Pending a vote by its board of directors, management believes temporarily holding the reverse split or canceling the reverse split altogether may be the best future course of action. “
Jimmy Chan, CEO of Sugarmade commented, “For at least the time being, we do not see a reason to move forward with the reverse stock split. However, we reserve the right, should circumstances warrant, to reactivate the reverse. We are in the process of modifying our business strategy to better align with where the cannabis marketplace is headed and thus our cancellation of the previously proposed transaction. We see significantly larger opportunities in the California cannabis distribution arena and have entered into advanced talks to make a strategic move into this area.”
It sure looks that way. Excellent bid repopulation — strong support just above $0.01. Big move upwards coming shortly.
Yes, and according to the filings, the rumor has merit because the DEF 14C was never filed after the PRE 14C was filed on 11/15/19 — 60 days has passed
“On November 13, 2019, the Company’s Board of Directors unanimously approved the of the Reverse Split of the issued and outstanding shares of Common Stock, including shares of Common Stock reserved for issuance, in a ratio and at a time and date to be determined by the Company’s Board of Directors, not to exceed a one for three hundred (1:300) basis within sixty (60) days from the date of filing of this amended Information Statement on Form 14C with the SEC (the “Reverse Split”).”
https://www.otcmarkets.com/filing/html?id=13746895&guid=BFojU6rtmHaweth
New website is in the works — sugarmade.com now has a picture of cookies and cannabis flower together. Appears that SGMD will be getting into edibles. The webpage says, “Something sweet is coming soon...:)”
http://sugarmade.com
This is going to move fast with positive news coming now as approx. 1.2B shares have been returned to SGMD treasury — reducing the outstanding shares to approximately 706 million :)
Watching for news on legal cannabis/hemp/CBD acquisition and/or cancellation of RS
CANB is the only Pure/Isolate CBD Oil Stock. If you have been paying close attention to proposed CBD legislation, you will notice the language is specific for Pure CBD (CBD Isolate), which initially will be the first form of CBD to be sold nationally. Now, anything can happen, but I’m positioning myself in stocks that focus on Pure/Isolate CBD. Full and Broad Spectrum formulations are excellent, but from my analysis, it won’t be allowed initially for national sales. The market is dumb and hasn’t separated the cannabis sector, and more specifically, has not divided the multiple formulations of the CBD sector. Canopy first formulation of CBD is Pure/Isolate — the biggest company in the cannabis sector chose Pure/Isolate CBD. CANB is a guaranteed winner at current price. Blue skies coming in first half of 2020.
With an announcement that the RS has been canceled along with news of an acquisition in Cannabis/Hemp/CBD sector, and let’s not forget the incredible change in share structure (~ 1.2B shares returned to treasury), will have SGMD in new 52wk-highs. Nonetheless, I will be adding aggressively under $0.013 — price point entry is key, and anything in the low $0.01’s is excellent accumulation territory for an easy double.
The DEF 14C hasn’t been filed for the RS